Civista Bancshares, Inc. (CIVB) EPS Estimated At $0.30; Cvs Health (CVS) SI Decreased By 2.79%

January 6, 2018 - By Maria Brooks

Cvs Health Corporation (NYSE:CVS) had a decrease of 2.79% in short interest. CVS’s SI was 24.87M shares in January as released by FINRA. Its down 2.79% from 25.58M shares previously. With 8.03 million avg volume, 3 days are for Cvs Health Corporation (NYSE:CVS)’s short sellers to cover CVS’s short positions. The stock increased 4.42% or $3.32 during the last trading session, reaching $78.45. About 15.34 million shares traded or 54.28% up from the average. CVS Health Corporation (NYSE:CVS) has declined 24.40% since January 6, 2017 and is downtrending. It has underperformed by 41.10% the S&P500.

Analysts expect Civista Bancshares, Inc. (NASDAQ:CIVB) to report $0.30 EPS on January, 26.They anticipate $0.03 EPS change or 9.09% from last quarter’s $0.33 EPS. CIVB’s profit would be $3.05 million giving it 18.46 P/E if the $0.30 EPS is correct. After having $0.29 EPS previously, Civista Bancshares, Inc.’s analysts see 3.45% EPS growth. The stock increased 0.64% or $0.14 during the last trading session, reaching $22.15. About 18,933 shares traded. Civista Bancshares, Inc. (NASDAQ:CIVB) has risen 81.83% since January 6, 2017 and is uptrending. It has outperformed by 65.13% the S&P500.

Among 6 analysts covering Civista Bancshares (NASDAQ:CIVB), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Civista Bancshares had 13 analyst reports since April 25, 2016 according to SRatingsIntel. Keefe Bruyette & Woods maintained the stock with “Buy” rating in Friday, July 28 report. On Tuesday, November 29 the stock rating was upgraded by Wood to “Outperform”. The rating was upgraded by Hovde Group to “Outperform” on Monday, April 25. The stock has “Buy” rating by Sandler O’Neill on Monday, October 24. The stock of Civista Bancshares, Inc. (NASDAQ:CIVB) has “Market Perform” rating given on Monday, July 11 by Hovde Group. The stock has “Outperform” rating by Keefe Bruyette & Woods on Tuesday, November 29. The company was initiated on Tuesday, December 13 by Boenning & Scattergood. The rating was maintained by Hovde Group on Wednesday, January 3 with “Hold”. Hovde Group maintained the stock with “Market Perform” rating in Monday, October 24 report. The stock of Civista Bancshares, Inc. (NASDAQ:CIVB) earned “Buy” rating by Keefe Bruyette & Woods on Tuesday, October 3.

Civista Bancshares, Inc. operates as the holding firm for Civista Bank that engages in the community banking business in Ohio. The company has market cap of $225.29 million. The companyÂ’s deposit products include noninterest-bearing and interest-bearing demand deposits, money market deposit accounts, and certificates of deposit. It has a 17.04 P/E ratio. The Company’s loan portfolio comprises residential real estate mortgages, commercial real estate loans, commercial and agriculture loans, real estate construction loans, and consumer loans.

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services. The company has market cap of $79.48 billion. It operates through Pharmacy Services and Retail/LTC divisions. It has a 16.17 P/E ratio. The Pharmacy Services segment offers pharmacy benefit management solutions, such as plan design and administration, formulary management, Medicare Part D services, mail order, specialty pharmacy and infusion services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services.

Since August 16, 2017, it had 0 buys, and 7 insider sales for $58.32 million activity. Roberts Jonathan C had sold 85,743 shares worth $7.13 million. 2,500 CVS Health Corporation (NYSE:CVS) shares with value of $199,050 were sold by SWIFT RICHARD J. Moriarty Thomas M sold $7.19M worth of stock or 90,267 shares. Foulkes Helena had sold 39,340 shares worth $3.22 million. Denton David M sold $18.88 million worth of stock. $20.03 million worth of CVS Health Corporation (NYSE:CVS) was sold by MERLO LARRY J on Wednesday, August 23.

Investors sentiment decreased to 0.88 in 2017 Q3. Its down 0.04, from 0.92 in 2017Q2. It turned negative, as 60 investors sold CVS Health Corporation shares while 571 reduced holdings. 88 funds opened positions while 466 raised stakes. 801.45 million shares or 0.31% less from 803.96 million shares in 2017Q2 were reported. Northstar Group Inc has invested 1.19% in CVS Health Corporation (NYSE:CVS). Financial Bank Pictet & Cie (Asia) Limited owns 44,270 shares. Beacon Fincl owns 0.94% invested in CVS Health Corporation (NYSE:CVS) for 64,180 shares. Carret Asset Management Lc owns 95,128 shares or 1.25% of their US portfolio. Reliance Tru Of Delaware invested in 44,008 shares or 0.54% of the stock. The Oregon-based Becker Capital Management has invested 0.01% in CVS Health Corporation (NYSE:CVS). Northeast Consultants Inc accumulated 0.23% or 7,849 shares. Palo Capital Inc holds 31,291 shares. Susquehanna Intl Limited Liability Partnership owns 169,252 shares or 0.01% of their US portfolio. Chicago Equity Prtn Limited Company owns 65,110 shares for 0.17% of their portfolio. Lowe Brockenbrough & Inc reported 26,974 shares. Coho Partners Ltd holds 4.49% in CVS Health Corporation (NYSE:CVS) or 2.15 million shares. Edmp has 0.9% invested in CVS Health Corporation (NYSE:CVS). Mackenzie Fincl Corporation holds 0.48% or 1.10 million shares in its portfolio. 1.84 million are held by California State Teachers Retirement.

Among 25 analysts covering CVS Health (NYSE:CVS), 18 have Buy rating, 0 Sell and 7 Hold. Therefore 72% are positive. CVS Health had 64 analyst reports since July 22, 2015 according to SRatingsIntel. Jefferies maintained the shares of CVS in report on Wednesday, August 16 with “Hold” rating. The stock of CVS Health Corporation (NYSE:CVS) has “Neutral” rating given on Friday, November 3 by Citigroup. The rating was maintained by RBC Capital Markets on Monday, December 4 with “Buy”. On Monday, August 24 the stock rating was upgraded by Vetr to “Buy”. The stock of CVS Health Corporation (NYSE:CVS) earned “Neutral” rating by Atlantic Securities on Monday, February 6. The stock of CVS Health Corporation (NYSE:CVS) earned “Outperform” rating by Oppenheimer on Friday, August 28. The firm has “Buy” rating by SunTrust given on Thursday, January 4. As per Monday, November 2, the company rating was maintained by S&P Research. Robert W. Baird maintained CVS Health Corporation (NYSE:CVS) rating on Friday, October 27. Robert W. Baird has “Hold” rating and $77.0 target. Mizuho maintained the shares of CVS in report on Thursday, June 23 with “Buy” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com